Skip to main content
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. logo

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. — Investor Relations & Filings

Ticker · 2395 ISIN · JP3379950003 LEI · 529900C10QR47J2U5R44 T Professional, scientific and technical activities
Filings indexed 68 across all filing types
Latest filing 2021-06-30 Annual Report
Country JP Japan
Listing T 2395

About SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.

https://en.snbl.com/

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a contract research organization (CRO) providing comprehensive drug development services. Established in 1957 as Japan's first CRO, the company supports pharmaceutical clients throughout the development lifecycle, from preclinical safety studies to clinical trial management. SNBL offers a full suite of services, including safety assessments and clinical data management. A key area of innovation is its proprietary nasal drug delivery technology, SMART (Simple MucoAdhesive Release Technology). The company's mission is to contribute to medical advancement and alleviate patient suffering by supporting the creation of new pharmaceuticals.

Recent filings

Filing Released Lang Actions
有価証券報告書-第48期(令和2年4月1日-令和3年3月31日)
Annual Report
2021-06-30 Japanese
四半期報告書-第48期第3四半期(令和2年10月31日-令和2年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Shin Nippon Biomedical Laboratories, Ltd., covering the third quarter of the 48th fiscal year (period ending December 31, 2020). It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as management analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-02-05 Japanese
四半期報告書-第48期第2四半期(令和2年7月1日-令和2年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Shin Nippon Biomedical Laboratories, Ltd. for the second quarter of the 48th fiscal period (ending September 30, 2020). It contains detailed financial statements, management analysis, and auditor review information, which aligns with the definition of an Interim/Quarterly Report (IR). Q2 2021
2020-11-06 Japanese
四半期報告書-第48期第1四半期(令和2年4月1日-令和2年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Shin Nippon Biomedical Laboratories, Ltd. covering the first quarter of the 48th fiscal year (April 1, 2020, to June 30, 2020). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as management analysis and notes. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. Q1 2021
2020-08-07 Japanese
有価証券報告書-第47期(平成31年4月1日-令和2年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains comprehensive financial statements, business descriptions, and management analysis for the fiscal year ending March 31, 2020. The document header explicitly identifies it as a 'Securities Report' (有価証券報告書) submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. FY 2020
2020-06-26 Japanese
四半期報告書-第47期第3四半期(令和1年10月1日-令和1年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Shin Nippon Biomedical Laboratories, Ltd. for the third quarter of the 47th fiscal period (ending December 31, 2019). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as management analysis. This fits the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-02-10 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.